Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-025840
Filing Date
2024-07-01
Accepted
2024-07-01 17:15:16
Documents
4
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 383280
2 formdef14a_001.jpg GRAPHIC 27613
3 proxy_001.jpg GRAPHIC 254048
4 proxy_002.jpg GRAPHIC 166828
  Complete submission text file 0001493152-24-025840.txt   1002617
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36268 | Film No.: 241091793
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)